These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Invasion of vaginal epithelial cells by uropathogenic Escherichia coli. Brannon JR; Dunigan TL; Beebout CJ; Ross T; Wiebe MA; Reynolds WS; Hadjifrangiskou M Nat Commun; 2020 Jun; 11(1):2803. PubMed ID: 32499566 [TBL] [Abstract][Full Text] [Related]
5. Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection. Schwartz DJ; Chen SL; Hultgren SJ; Seed PC Infect Immun; 2011 Oct; 79(10):4250-9. PubMed ID: 21807904 [TBL] [Abstract][Full Text] [Related]
6. Detection of intracellular bacterial communities in a child with Escherichia coli recurrent urinary tract infections. Robino L; Scavone P; Araujo L; Algorta G; Zunino P; Vignoli R Pathog Dis; 2013 Aug; 68(3):78-81. PubMed ID: 23733378 [TBL] [Abstract][Full Text] [Related]
7. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. Duell BL; Carey AJ; Tan CK; Cui X; Webb RI; Totsika M; Schembri MA; Derrington P; Irving-Rodgers H; Brooks AJ; Cripps AW; Crowley M; Ulett GC J Immunol; 2012 Jan; 188(2):781-92. PubMed ID: 22184725 [TBL] [Abstract][Full Text] [Related]
8. Host subversion by formation of intracellular bacterial communities in the urinary tract. Anderson GG; Martin SM; Hultgren SJ Microbes Infect; 2004 Oct; 6(12):1094-101. PubMed ID: 15380779 [TBL] [Abstract][Full Text] [Related]
9. A Murine Model for Escherichia coli Urinary Tract Infection. Hannan TJ; Hunstad DA Methods Mol Biol; 2016; 1333():159-75. PubMed ID: 26468108 [TBL] [Abstract][Full Text] [Related]
10. Revisiting the Escherichia coli polysaccharide capsule as a virulence factor during urinary tract infection: contribution to intracellular biofilm development. Goller CC; Seed PC Virulence; 2010; 1(4):333-7. PubMed ID: 21178466 [TBL] [Abstract][Full Text] [Related]
11. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli. Ejrnæs K Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767 [TBL] [Abstract][Full Text] [Related]
12. Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli. Horvath DJ; Li B; Casper T; Partida-Sanchez S; Hunstad DA; Hultgren SJ; Justice SS Microbes Infect; 2011 May; 13(5):426-37. PubMed ID: 21182979 [TBL] [Abstract][Full Text] [Related]
13. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. Hannan TJ; Totsika M; Mansfield KJ; Moore KH; Schembri MA; Hultgren SJ FEMS Microbiol Rev; 2012 May; 36(3):616-48. PubMed ID: 22404313 [TBL] [Abstract][Full Text] [Related]
14. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Mulvey MA; Schilling JD; Hultgren SJ Infect Immun; 2001 Jul; 69(7):4572-9. PubMed ID: 11402001 [TBL] [Abstract][Full Text] [Related]
15. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118 [TBL] [Abstract][Full Text] [Related]